Literature DB >> 16492624

A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia: 1953-2003.

A K Thomson1, E J Glasson, A H Bittles.   

Abstract

PURPOSE: To investigate the incidence, clinical presentation and associated comorbidities of Angelman syndrome (AS) in Western Australia, with establishment of an information database for the disorder.
METHODS: Data were collected from Disability Services Commission files, supplemented by datasets provided by the Western Australian Data Linkage Unit. The analysis was retrospective and quantitative.
RESULTS: Thirty-four individuals (two deceased) were identified (19 F, 15 M), with a mean age of 21.6 years; 52.9% had an IQ < 40, with the remainder of IQ 40-69. The incidence was one in 40,000 births and mean age at diagnosis was 5.8 years. The mean age of the 23 home residents was 20.2 years compared to 27.9 years in the nine individuals in sheltered accommodation. In general, the patients exhibited a typical AS clinical presentation. A median of 5.5 (range 0-20) hospital admissions was recorded per person, with epilepsy, gastrointestinal disorders, and dental work all common reasons for admission.
CONCLUSIONS: The estimated incidence was low compared to other reports, as was the proportion of IQ < 40. AS cases required substantial levels of medical care, especially those who were epileptic. An increase in the future numbers of AS patients needing sheltered accommodation is predicted.

Entities:  

Mesh:

Year:  2006        PMID: 16492624     DOI: 10.1080/09638280500190631

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  14 in total

1.  Mutation in the SLC9A6 gene is not a frequent cause of sporadic Angelman-like syndrome.

Authors:  Yann Fichou; Nadia Bahi-Buisson; Juliette Nectoux; Jamel Chelly; Delphine Héron; Laurence Cuisset; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

2.  Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.

Authors:  Daren Low; Ken-Shiung Chen
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

Review 3.  Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.

Authors:  Ece D Gamsiz; Laura N Sciarra; Abbie M Maguire; Matthew F Pescosolido; Laura I van Dyck; Eric M Morrow
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Diagnostic approach of angelman syndrome.

Authors:  Denis George Duca; Dana Craiu; Monica Boer; Sorina Mihaela Chirieac; Aurora Arghir; Andreea Tutulan-Cunita; Diana Barca; Catrinel Iliescu; Agripina Lungeanu; Sanda Magureanu; Magdalena Budisteanu
Journal:  Maedica (Buchar)       Date:  2013-09

Review 5.  [Anesthesia and Angelman syndrome].

Authors:  W Witte; C Nobel; J Hilpert
Journal:  Anaesthesist       Date:  2011-03-16       Impact factor: 1.041

6.  Angelman syndrome in adulthood.

Authors:  Anna M Larson; Julianna E Shinnick; Elias A Shaaya; Elizabeth A Thiele; Ronald L Thibert
Journal:  Am J Med Genet A       Date:  2014-11-26       Impact factor: 2.802

Review 7.  Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases.

Authors:  Krystal L Tomei; Christine Y Mau; Michael Ghali; Jayoung Pak; Ira M Goldstein
Journal:  Childs Nerv Syst       Date:  2018-01-19       Impact factor: 1.475

8.  The Cost of Raising Individuals with Fragile X or Chromosome 15 Imprinting Disorders in Australia.

Authors:  Emma K Baker; Sheena Arora; David J Amor; Perrin Date; Meagan Cross; James O'Brien; Chloe Simons; Carolyn Rogers; Stephen Goodall; Jennie Slee; Chris Cahir; David E Godler
Journal:  J Autism Dev Disord       Date:  2021-07-22

9.  SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

Authors:  Gregor D Gilfillan; Kaja K Selmer; Ingrid Roxrud; Raffaella Smith; Mårten Kyllerman; Kristin Eiklid; Mette Kroken; Morten Mattingsdal; Thore Egeland; Harald Stenmark; Hans Sjøholm; Andres Server; Lena Samuelsson; Arnold Christianson; Patrick Tarpey; Annabel Whibley; Michael R Stratton; P Andrew Futreal; Jon Teague; Sarah Edkins; Jozef Gecz; Gillian Turner; F Lucy Raymond; Charles Schwartz; Roger E Stevenson; Dag E Undlien; Petter Strømme
Journal:  Am J Hum Genet       Date:  2008-03-13       Impact factor: 11.025

Review 10.  Unmet clinical needs and burden in Angelman syndrome: a review of the literature.

Authors:  Anne C Wheeler; Patricia Sacco; Raquel Cabo
Journal:  Orphanet J Rare Dis       Date:  2017-10-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.